Award Synopsis Molecular.pdf

PDF 116 KB Posted

Attached to
Design and Engineering of VesiVax® HIV Immunogen Formulations”
Solicitation number
75N93024C00018
Issued by

About this file

This is an Award Synopsis document for contract number 75N93024C00018 awarded to Molecular Express, Inc. for the "Design and Engineering of VesiVax® HIV Immunogen Formulations" project.

The contract was awarded on June 25, 2024, with a period of performance from July 1, 2024 through June 30, 2026. The total estimated cost including all options is $1,999,866. The work falls under NAICS code 541715 (Research and Development in the Physical, Engineering, and Life Sciences) and PSC code AN12. The place of performance is in Rancho Dominguez, CA. The contracting agency is the National Institute of Allergy and Infectious Diseases (NIAID), with Christopher Ray serving as Contract Specialist and Robert Corno as the Contracting Officer. The contract originated from RFP No. PHS 2020-1.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

AWARD SYNOPSIS

Type: Award

Date of Award: June 25, 2024

Period of Performance (including all options): July 1, 2024 through June 30, 2026

Title: “Design and Engineering of VesiVax® HIV Immunogen Formulations”

(RFP) No.: PHS 2020-1

NAICS: 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Contract Number: 75N93024C00018

PSC: AN12

Total Estimated Cost (Including all Options): $1,999,866

Place of Performance/Awardee:

Molecular Express, Inc.

2630 Homestead Place Rancho Dominguez, CA 90220

UEID: R1JMHFESEKD5

Primary Point of Contact at NIAID: Christopher Ray Contract Specialist chris.ray@nih.gov

Secondary Point of Contact at NIAID: Robert Corno Contracting Officer cornorj@niaid.nih.gov mailto:chris.ray@nih.gov mailto:cornorj@niaid.nih.gov

File details come from the government source that posted it. Updated .